Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis

INTRODUCTION: Low-dose interleukin-2 (IL-2) selectively restores disturbances of regulatory T cells (Treg) and conventional T cells, resulting in the induction of remission in patients with systemic lupus erythematosus. However, to date no research has been carried out on the efficacy of low-dose IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xia, Feng, Ruiling, Shao, Miao, Wang, Yifan, Sun, Xiaolin, He, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572262/
https://www.ncbi.nlm.nih.gov/pubmed/34618348
http://dx.doi.org/10.1007/s40744-021-00381-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572262/
https://www.ncbi.nlm.nih.gov/pubmed/34618348
http://dx.doi.org/10.1007/s40744-021-00381-1

Ejemplares similares